Skip to content

Author

Hongjian Liu

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

USP36-mediated stabilization of NAT10 promotes osteosarcoma progression via ac4C-dependent KIF23 mRNA stabilization.

Osteosarcoma is an aggressive bone malignancy with a propensity for pulmonary metastasis, yet the molecular mechanisms linking protein homeostasis to epitranscriptomic regulation remain incompletely understood. Here, integrated transcriptomic, survival, protein-interaction, and CRISPR dependency analyses identified the...

Yan-Fei Wu, Li-Ping Ma, Zhao-Qi Chen et al. · 0 citations
Open access Jul 2026

Inhibition of ETS1/DRP1 axis attenuates intervertebral disc degeneration by suppressing excessive mitochondrial fission.

Intervertebral disc degeneration (IVDD) is a predominant contributor to low back pain, characterized by nucleus pulposus cell (NPC) senescence, extracellular matrix (ECM) metabolic dysfunction, and chronic inflammation. Excessive mitochondrial fission contributes to IVDD, yet the underlying regulatory mechanisms remain...

Pengfei Li, Yichen Que, Shuhao Zhang et al. · 0 citations
Open access Aug 2026

DSCAM‐AS1 Facilitates Osteosarcoma Progression via Regulating miR‐211‐5p/PDCD6 Axis

Among adolescents worldwide, osteosarcoma (OS) is one of the most frequently occurring cancers. DSCAM‐AS1, a recognized lncRNA, has been noted for its abnormal expression in the development of certain cancers, but its role in OS is still unclear. Quantification of DSCAM‐AS1, miR‐211‐5p, and PDCD6 expression was carried...

Qi Wang, Yunzheng Zhao, Long-Bao Shi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.